Purchase our immunology module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
The advent of biologic therapy has revolutionized the treatment of many immunological diseases, including rheumatoid arthritis and psoriasis.
Humira and Enbrel are now among the best-selling drugs in the world. Their looming patent expirations and the unclear future of biosimilars make immunology one of the most intriguing and difficult-to-predict markets in the pharmaceutical industry.
GlobalData's therapy module includes coverage from prevalent diseases such as systemic lupus erythematosus to niche indications such as Wilson’s disease.